Printed From BioPortfolio.com

SU2C launches 'cancer interception' initiative to detect & treat cancer at earliest stages

20:00 EDT 25 Oct 2017 | AAAS

(Entertainment Industry Foundation) Stand Up To Cancer (SU2C), the Lustgarten Foundation for Pancreatic Cancer Research, LUNGevity, and the American Lung Association, have awarded a total of $16.6 million to four teams of top researchers to carry out an attack on cancers of the lung and pancreas using a radical new approach of "interception" of cancers at very early stages when they can be more successfully treated, even catching precancerous cells and blocking them from turning into cancer cells.

Original Article: SU2C launches 'cancer interception' initiative to detect & treat cancer at earliest stages

More From BioPortfolio on "SU2C launches 'cancer interception' initiative to detect & treat cancer at earliest stages"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search

Relevant Topics

Cancer
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake. Diagnosis is based on clinical presentation...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches